Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Foundation Guild is a functionally cohesive group of beneficial gut bacteria crucial for structuring and stabilizing the human gut microbiome. These bacteria primarily break down dietary fibers and produce short-chain fatty acids (SCFAs), such as butyrate, essential for maintaining gut health. Key genera include Prevotella, Coprococcus, Clostridium fessum, Lachnospira, Veillonella, Faecalibacterium spp., and Roseburia inulinivorans. The Foundation Guild supports gut barrier integrity, reduces inflammation, and suppresses the growth of potentially harmful bacteria. It is considered a therapeutic target for personalized nutrition and microbiota transplantation to prevent dysbiosis and promote overall health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Foundation Guild Bacteria.